These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 692381)

  • 21. Role of fatty acid oxidation in food intake and hunger motivation in Syrian hamsters.
    Schneider JE; Lazzarini SJ; Friedman MI; Wade GN
    Physiol Behav; 1988; 43(5):617-23. PubMed ID: 3200917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
    Tutwiler GF; Bridi G
    Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic and behavioral responses in pre-weanling rats following alteration of maternal diet.
    Swithers SE; Melendez RI; Watkins BA; Davis RJ
    Physiol Behav; 2001 Jan; 72(1-2):147-57. PubMed ID: 11239992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that medium-chain fatty acid oxidation can support an active gluconeogenesis in the suckling newborn rat.
    Turlan P; Ferre P; Girard JR
    Biol Neonate; 1983; 43(1-2):103-8. PubMed ID: 6850010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic control of prevention of nephropathy by 2-tetradecylglycidate in the diabetic mouse (db/db).
    Lee SM; Tutwiler G; Bressler R; Kircher CH
    Diabetes; 1982 Jan; 31(1):12-8. PubMed ID: 6759207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of blockade of fatty acid oxidation on whole body and tissue-specific glucose metabolism in rats.
    Jenkins AB; Storlien LH; Cooney GJ; Denyer GS; Caterson ID; Kraegen EW
    Am J Physiol; 1993 Oct; 265(4 Pt 1):E592-600. PubMed ID: 8238335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate on fatty acid and glucose metabolism in perfused rat hearts determined using iodine-125 16-iodohexadecanoate.
    Sherratt HS; Gatley SJ; DeGrado TR; Ng CK; Holden JE
    Biochem Biophys Res Commun; 1983 Dec; 117(3):653-7. PubMed ID: 6667268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutrition and somatomedin. XXI. Insulin-like growth factor-I and somatomedin inhibitor in streptozotocin-diabetic rats: relation to ketogenesis and gluconeogenesis.
    Gagliardi AR; Goldstein S; Phillips LS
    Metabolism; 1990 Jan; 39(1):75-80. PubMed ID: 2403622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The longitudinal effect of inhibiting fatty acid oxidation in diabetic rats fed a high fat diet.
    Barnett M; Collier GR; O'Dea K
    Horm Metab Res; 1992 Aug; 24(8):360-2. PubMed ID: 1526621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of the metabolic effects of 2-tetradecylglycidate by octanoic acid in the genetically diabetic mouse (db/db).
    Lee SM; Bahl JJ; Bressler R
    Biochem Med; 1985 Feb; 33(1):104-9. PubMed ID: 3994695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced induction of carbohydrate utilization by inhibition of fatty acid oxidation in myocytes from diabetic animals.
    Abdel-aleem S; Sharwi S; Badr M; Sayed-Ahmed M; Anstadt MP; Lowe JE
    Horm Metab Res; 1995 Feb; 27(2):104-6. PubMed ID: 7759056
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydrazonopropionic acids, a class of hypoglycemic substances. 1. Hypoglycemic effect of 2-(phenylethylhydrazono)- and 2-(2-cyclohexyl-ethylhydrazono)-propionic acid.
    Haeckel R; Oellerich M
    Horm Metab Res; 1979 Nov; 11(11):606-11. PubMed ID: 535878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent.
    Kunoh Y; Iguchi A; Gotoh M; Nomura T; Shibata M; Sakamoto N
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):302-13. PubMed ID: 3521517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver.
    Ide T; Ontko JA
    J Biol Chem; 1981 Oct; 256(20):10247-55. PubMed ID: 7287708
    [No Abstract]   [Full Text] [Related]  

  • 36. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes.
    Reaven GM; Chang H; Hoffman BB
    Diabetes; 1988 Jan; 37(1):28-32. PubMed ID: 3275556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute gliclazide administration enhances glucose and ketone body utilization in the perfused hind limb of normal and streptozotocin-diabetic rats.
    Okuda Y; Kobayashi K; Ohmori H; Sone H; Suzuki M; Ma J; Nakajima T; Yamada N; Yamashita K
    Life Sci; 2002 Jun; 71(6):647-54. PubMed ID: 12072153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of methyl-2-tetradecylglycidate (McNeil 3716) on heart mitochondrial metabolism in rats.
    Bachmann E; Weber E; Zbinden G
    Biochem Pharmacol; 1984 Jun; 33(12):1947-50. PubMed ID: 6732853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypoglycemic action of certain heterocyclic carboxylic acid derivatives].
    Takasaki K; Kaneko M; Fujii T; Kobayashi H
    Nihon Yakurigaku Zasshi; 1973 Nov; 69(6):977-94. PubMed ID: 4799525
    [No Abstract]   [Full Text] [Related]  

  • 40. [Inhibitors of beta-oxidation of fatty acids (review)].
    Kendysh IN
    Vopr Med Khim; 1984; 30(2):18-27. PubMed ID: 6377685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.